Thymalfasin is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-07-03. Where a claim depends on a specific study, the study is described rather than over-claimed.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is supplied as a lyophilized powder in most research settings. The solid dissolves readily in water and in common aqueous buffers, and it is typically reconstituted shortly before use. Solutions are clear and colourless at ordinary working concentrations. Because the peptide is hygroscopic, weighing and reconstitution are usually performed with minimal exposure to ambient air. Aliquots are prepared to avoid repeated freeze-thaw cycles, and working solutions are kept cold.
Long-term storage is generally at minus twenty degrees Celsius or colder, preferably desiccated and protected from light. Lyophilized material is more stable than reconstituted solution, which degrades faster at room temperature. Stability depends on pH, ionic strength, and the presence of oxidising agents. Published stability data for the peptide are limited, so storage claims in catalogues should be treated as general guidance rather than measured guarantees. Freeze-thaw cycles are kept to a minimum.
Identity and purity are normally confirmed by reversed-phase high-performance liquid chromatography and mass spectrometry. The expected mass for the acetylated 28-residue peptide is close to 3108 daltons, and a mass shift indicates a modification or truncation. Peptide mapping after enzymatic digestion can resolve sequence-level questions. Counter-ion content, water content, and residual solvents are separate quality attributes that a certificate of analysis may or may not report. Aggregation is monitored by size-exclusion chromatography when relevant.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide, 28 residues | N-terminal fragment of prothymosin alpha |
| Molecular mass | About 3108 Da | Acetylated form |
| Isoelectric point | Near 4.2 | Acidic peptide |
| Appearance | White to off-white lyophilized powder | Common supplied form |
| Typical storage | -20 °C or below, dry | Solution stability is lower |
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography, which separates the peptide from closely related impurities and from truncated or oxidized variants. Mass spectrometry supplies the molecular mass and confirms the expected sequence length, while amino acid analysis can be used to check composition. Because the molecule has no chromophore beyond the peptide backbone, ultraviolet detection is typically performed at a low wavelength, where baseline interference from solvents and buffers is a practical concern. Water content and counter-ion content are often reported alongside purity.
Practical handling focuses on limiting adsorption and contamination. The peptide dissolves readily in water, and dilute solutions tend to adhere to plastic and glass surfaces, so an inert carrier protein or a defined buffer can reduce losses in laboratory work. Workers also record the counter-ion form, since an acetate or trifluoroacetate salt changes the mass balance of the weighed powder. Documentation of lot number, purity value, and storage history supports reproducibility when results from different laboratories are compared.
== History == The oxymetazoline brand Afrin was first sold as a prescription medication in 1966. After finding substantial early success as a prescription medication, it became available as an over-the-counter drug in 1975. Schering-Plough did not engage in heavy advertising until 1986.
=== Packaging === For some forms of treatment, packaging is used to ensure the food stuffs never come in contact with radioactive substances and prevent re-contamination of the final product. Food processors and manufacturers today struggle with using affordable, efficient packaging materials for irradiation-based processing. The implementation of irradiation on prepackaged foods has been found to impact foods by inducing specific chemical alterations to the food packaging material that migrates into the food. Cross-linking in various plastics can lead to physical and chemical modifications that can increase the overall molecular weight. On the other hand, chain scission is fragmentation of polymer chains that leads to a molecular mass reduction.
Heat or ionizing irradiation can be used to kill the bacteria that cause decomposition. Heat is applied by cooking, blanching or microwave heating in a manner that pasteurizes or sterilizes fish products. Cooking or pasteurizing does not completely inactivate microorganisms and may need to be followed with refrigeration to preserve fish products and increase their shelf life. Sterilised products are stable at ambient temperatures up to 40 °C, but to ensure they remain sterilized they need packaging in metal cans or retortable pouches before the heat treatment.
Sources: en.wikipedia.org
In 1995, Ice-T had a recurring role as vengeful drug dealer Danny Cort on the television series New York Undercover, co-created by Dick Wolf. His work on the series earned him the 1996 NAACP Image Award for Outstanding Supporting Actor in a Drama Series. In 1997, he co-created the short-lived series Players, produced by Wolf. This was followed by a role as pimp Seymour "Kingston" Stockton in Exiled: A Law & Order Movie (1998). These collaborations led Wolf to add Ice-T to the cast of Law & Order: Special Victims Unit. Since 2000, he has portrayed Odafin "Fin" Tutuola, a former undercover narcotics officer transferred to the Special Victims Unit. In 2002, the NAACP awarded Ice-T with a second Image Award, again for Outstanding Supporting Actor in a Drama Series, for his work on Law & Order: SVU. Around 1995, Ice-T co-presented a UK-produced magazine television series on black culture, Baadasss TV. In 1997, Ice-T had a pay-per-view special titled Ice-T's Extreme Babes which appeared on Action PPV, formerly owned by BET Networks. In 1999, Ice-T starred in the HBO film Stealth Fighter as a United States Naval Aviator who fakes his own death, steals an F-117 stealth fighter, and threatens to destroy United States military bases. He also acted in the film Sonic Impact, released the same year. Ice-T made an appearance on the comedy television series Chappelle's Show as himself presenting the award for "Player Hater of the Year" at the "Player-Haters Ball", a parody of his own appearance at the Players Ball. He was dubbed the "Original Player Hater".
=== February 2004 === Death in U.S. custody of chemistry professor Mohammed Munim al-Izmerly. An autopsy concluded death was caused by a sudden hit to the back of his head and that the cause of death was blunt trauma.
== Installations == NNPC has sole responsibility for upstream and downstream developments. In 1988, the corporation was commercialised into 11 strategic business units, covering the entire spectrum of oil industry operations: exploration and production, gas development, refining, distribution, petrochemicals, engineering, and commercial investments.
Sources: en.wikipedia.org
This will happen only when the analyzer is rotated by the same angle by which the plane of polarization of light is rotated by the optically active solution. The position of the analyzer is again noted. The difference of the two readings will give the angle of rotation of the plane of polarization. A difficulty faced in the above procedure is that when analyzer is rotated for the total darkness, then it is attained gradually and hence it is difficult to find the exact position correctly for which complete darkness is obtained. To overcome the above difficulty, the half-shade device is introduced between polarizer P and the glass tube T.
=== Stretch receptors === Stretch receptors have two parts: Spindle cells and Golgi tendons. Spindle cells, located in the center of a muscle, send messages for the muscle to contract. On the other hand, Golgi tendon receptors are located near the end of a muscle fiber and send messages for the muscle to relax. As these receptors are trained through continual use, stretching becomes easier. When reflexes that inhibit flexibility are released the splits then become easier to perform. The splits use the body's complete range of motion and provide a complete stretch.
== Target and molecular mechanism == When U7-CNTX-Pn1a was tested on HEK 293 cells that were transfected with rTRPV1, capsaicin receptor, induced inward Ca2+ currents were blocked. U7-CNTX-Pn1a inhibited the release of glutamate from the trigeminal ganglion. This together suggests that the toxin blocks TRPV1 receptors. In comparison to SB-366791, which is a selective TRPV1 blocker, the toxin was found to exert greater inhibitory potency as a much lower concentration was needed of the U7-CNTX-Pn1a, with an IC50 of 47 ± 0.18nM, 45 ± 1.18nM and 390 ± 5.1nM for the native, recombinant U7-CNTX-Pn1a and SB-366791, respectively. Additionally, in a neuropathic pain model the toxin was discovered to target L-type voltage-gated calcium channels (VGCCs) using L-type VGCC blockers. The mild antinociceptive effect reversed when U7-CNTX-Pn1a was administered to the mice (30 fmol/site, i.t.), however, the exact underlying mechanism was not discovered yet.
The recommended daily intakes for children aged three years and older is 10% to 20% higher than adult levels and those for infants can be as much as 150% higher in the first year of life. Cysteine (or sulfur-containing amino acids), tyrosine (or aromatic amino acids), and arginine are always required by infants and growing children. Methionine and cysteine are grouped together because one of them can be synthesized from the other using the enzyme methionine S-methyltransferase and the catalyst methionine synthase. Phenylalanine and tyrosine are grouped together because tyrosine can be synthesized from phenylalanine using the enzyme phenylalanine hydroxylase.
Sources: en.wikipedia.org
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.
Thymosin alpha-1 is a single defined 28-residue peptide, while the broader family includes unrelated peptides such as thymosin beta-4. The shared name reflects historical isolation from thymus tissue rather than a common structure. Confusion between the two is common in older literature.
No single pathway fully accounts for its reported effects. Several studies describe interaction with innate immune receptors and downstream cytokine changes, but the complete picture is not settled. Open questions remain about which effects occur at physiological concentrations.
Lyophilized powder is normally kept at minus twenty degrees Celsius or below, in a sealed container, desiccated and away from light. Reconstituted solutions are less stable and are usually refrigerated and used quickly. Repeated temperature cycling should be avoided.